Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome.

Châtel-Soulet HÉ, Juge S, Pereira AL, Seguin J, El Taher A, Valigi F, Jevtic Z, Sivalingam R, Bagger FO, Büschl P, Almosailleakh M, Tzankov A, Tong W, Kurokawa M, Nombela Arrieta C, Schwaller J

Open source

DOI: 10.1038/s41467-025-67611-w
Published: 2025 Dec 19
Container: Nature communications
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-025-67611-w,
  title = {Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome.},
  author = {Châtel-Soulet HÉ and Juge S and Pereira AL and Seguin J and El Taher A and Valigi F and Jevtic Z and Sivalingam R and Bagger FO and Büschl P and Almosailleakh M and Tzankov A and Tong W and Kurokawa M and Nombela Arrieta C and Schwaller J},
  year = {2025},
  journal = {Nature communications},
  doi = {10.1038/s41467-025-67611-w},
  url = {https://doi.org/10.1038/s41467-025-67611-w}
}

RIS

TY  - JOUR
TI  - Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome.
AU  - Châtel-Soulet HÉ
AU  - Juge S
AU  - Pereira AL
AU  - Seguin J
AU  - El Taher A
AU  - Valigi F
AU  - Jevtic Z
AU  - Sivalingam R
AU  - Bagger FO
AU  - Büschl P
AU  - Almosailleakh M
AU  - Tzankov A
AU  - Tong W
AU  - Kurokawa M
AU  - Nombela Arrieta C
AU  - Schwaller J
PY  - 2025
JO  - Nature communications
DO  - 10.1038/s41467-025-67611-w
UR  - https://doi.org/10.1038/s41467-025-67611-w
ER  -

APA

HÉ, C., S, J., AL, P., J, S., A, E. T., F, V., Z, J., R, S., FO, B., P, B., M, A., A, T., W, T., M, K., C, N. A., & J, S. (2025). Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome.. Nature communications. https://doi.org/10.1038/s41467-025-67611-w

Source records

pubmed · retrieved 2026-09-26T02:49:39.786Z
europe-pmc · retrieved 2026-09-26T02:49:39.769Z
doaj · retrieved 2026-09-26T02:49:39.763Z